However, recombinant hexosaminidases have not been completely characterized under different pH or temperature conditions.
The effect of pH on the activity of recombinant hexosaminidases was evaluated at 3.
Stability in human serum: To assess the stability of the recombinant hexosaminidases in human serum 1 [micro]L of each purified enzyme was incubated with 49 [micro]L of pooled human serum from healthy individuals.
Hence, recombinant [beta]-hexosaminidases were purified by ion exchange chromatography, according to reported isoelectric points for hexosaminidases extracted from human tissues [7, 12, 26].
Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase
A by activator protein.
A glycine250 to aspartate substitution in the [alpha]-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian Family.
M2] gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A.
Expression of hexosaminidase
isoenzymes in childhood leukemia.
Detection of heterozygotes and homozygotes by serum hexosaminidase assay.
Standardization of leukocytes for Tay-Sachs hexosaminidase assay [Abstract].
Automated determination of serum hexosaminidase A by pH inactivation for determination of Tay-Sachs disease heterozygotes.
The subunit and polypeptide structure of hexosaminidase
from human placenta.